Related references
Note: Only part of the references are listed.Neurofascin (NF) 155-and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP
Juliane Klehmet et al.
FRONTIERS IN NEUROLOGY (2017)
Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP
M. Staudt et al.
BMC NEUROLOGY (2017)
The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy
Vera Bril et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy
Jerome J. Devaux et al.
NEUROLOGY (2016)
Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials
Andrew Fiore-Gartland et al.
PLOS ONE (2016)
The Loss of BKV-specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication
T. Schachtner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Circulating lymphocyte and T memory subsets in glucocorticosteroid versus IVIG treated patients with CIDP
Juliane Klehmet et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders
Panos Stathopoulos et al.
NATURE REVIEWS NEUROLOGY (2015)
CIDP diagnostic pitfalls and perception of treatment benefit
Jeffrey A. Allen et al.
NEUROLOGY (2015)
Effective treatment with intravenous immunoglobulins reduces autoreactive T-cell response in patients with CIDP
Juliane Klehmet et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Myelination of the Nervous System: Mechanisms and Functions
Klaus-Armin Nave et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30 (2014)
Efficiency of long-term treatment with intravenous immunoglobulins correlates with reduced autoreactive T cell responses in chronic inflammatory demyelinating polyneuropathy patients
J. Klehmet et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Diagnosis and treatment of chronic acquired demyelinating polyneuropathies
Norman Latov
NATURE REVIEWS NEUROLOGY (2014)
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg
Luis Querol et al.
NEUROLOGY (2014)
The Characteristics of Chronic Inflammatory Demyelinating Polyneuropathy in Patients with and without Diabetes - An Observational Study
Samantha K. Dunnigan et al.
PLOS ONE (2014)
Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options
Filip Eftimov et al.
CURRENT OPINION IN NEUROLOGY (2013)
SENSORY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: AN UNDER-RECOGNIZED ENTITY?
Xavier Ayrignac et al.
MUSCLE & NERVE (2013)
Nodal proteins are target antigens in Guillain-Barre syndrome
Jerome J. Devaux et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2012)
Neurofascin as a target for autoantibodies in peripheral neuropathies
Judy King Man Ng et al.
NEUROLOGY (2012)
ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials
Anatoli M. Malyguine et al.
Cells (2012)
Advances in the diagnosis, pathogenesis and treatment of CIDP
Marinos C. Dalakas
NATURE REVIEWS NEUROLOGY (2011)
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice
Kenneth C. Gorson et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2010)
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2010)
A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy
Cedric Louvet et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
S. Janetzki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy
H. R. Inglis et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
PA Csurhes et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
CD28 costimulation enhances the sensitivity of the ELISPOT assay for detection of antigen-specific memory effector CD4 and CD8 cell populations in human diseases
PA Ott et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays
JR Currier et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies
ISJ Merkies et al.
MUSCLE & NERVE (2002)
Share Paper
